Latest Overdiagnosis Stories
A new study shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer.
Physicians advising men whether to be screened for prostate cancer with a PSA test must rely more on available evidence when recommending screening, biopsies and treatments rather than long held beliefs that PSA-based testing is beneficial for all, Beth Israel Deaconess Medical Center prostate expert Marc B. Garnick, MD, says.
The U.S. Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), and many debated which PSA level should lead to biopsy recommendation.
After the US Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), many debated which PSA level should lead to a biopsy recommendation.
For years, mammograms have been the best way to find breast cancer early, when it is easier to treat and before it is big enough to feel or cause symptoms.
A new study published on bmj.com today supports the claim that the introduction of breast cancer screening in the UK may have caused more harm than good.
The Canadian task force released new guidelines for women at risk of breast cancer. The guidelines recommend no routine mammography screenings for women aged 40-49 and extend the screening interval from every 2 years, which is current clinical practice, to every 2-3 years for women aged 50-74.
New breast cancer screening guidelines for women at average risk of breast cancer.
A model used to estimate breast cancer survival rates found that the probability that a woman with screen-detected breast cancer will avoid a breast cancer death because of screening mammography may be lower than previously thought.
- A transitional zone between two communities containing the characteristic species of each.